Exploring New Frontiers in Cancer Treatment
by Kim Thiboldeaux and Mitch Golant, PhD
Surgery, chemotherapy, and radiation remain the standard ways to treat cancer, but we look forward to the day when cancer treatment can be tailored to each individual – and a day when the word “cure” is more a part of our vocabulary. While cancer treatment is not yet at that point, scientists have made great advances in medical research, bringing us much closer to the goal of personalizing medicine.
Maintaining Quality of Life in the Face of Cancer-Related Pain
by Tanya J. Uritsky, PharmD
When I saw that Mary was returning to the hospital for a potentially curative treatment, I had to stop by her room. As I walked in, she immediately started to cry. I thought to myself, What did I do? Before I could complete that thought, she jumped up and hugged me. She said, “Tanya, you were able to do what no one has been able to do in 10 years. I was able to live again. Thank you.” This is treating pain in cancer – restoring quality of life and functionality.
New Report Estimates Nearly 18 Million Cancer Survivors in the U.S. by 2022
The number of Americans with a history of cancer, currently estimated to be more than 13 million, will grow to almost 18 million by 2022, according to a report by the American Cancer Society in collaboration with the National Cancer Institute. The report finds that even though cancer incidence rates are decreasing, the number of cancer survivors is growing due to the aging and growth of the population, as well as improving cancer survival rates.
New Developments in Cancer Research
The 2012 ASCO Annual Meeting was held in Chicago, Illinois, from June 1 through June 5, 2012. The ASCO Annual Meeting is the platform for the release of thousands of scientific abstracts – highly anticipated research news for many people, including patients, caregivers, and the general public.
The Path to Cancer Treatment Breakthroughs
It’s a simple question with no simple answer: When are you going to cure cancer? At the National Cancer Institute, the component of the National Institutes of Health tasked with leading America’s research efforts against all forms of this disease, we understand the urgency of the question; we also understand the fear of cancer that drives the search for answers. NCI’s efforts to reduce cancer incidence and mortality cover a wide range of research areas, including prevention, screening, early diagnosis, treatment, and survivorship efforts.
Know Your Fertility Options
by Teresa K. Woodruff, PhD, and Kate Waimey Timmerman, PhD
In April 2010, Tiffany and Dave were juggling their busy lives and in the midst of planning a European vacation when Tiffany noticed an unusual lump in her breast. As a typical, healthy 28-year-old, Tiffany assumed the lump was benign, and when she went to the doctor to have it checked, she was shocked to find out it was breast cancer. Immediately after her diagnosis, Tiffany was sent to a variety of specialists, including the fertility preservation patient navigator at Northwestern Memorial Hospital in Chicago, IL.
Managing Infections and Low White Blood Cell Counts
by Carlton G. Brown, PhD, RN, AOCN®
A low white blood cell count is a common side effect of some cancers and cancer treatment. When your white blood cell count is too low, you have a high risk of getting an infection. Infections can be very serious in people with cancer. If you get an infection or if your white blood cell count is very low, your chemotherapy may be delayed, and you may need to be treated in the hospital.
New Guide Helps Obese People with Cancer Understand Optimal Weight-Based Chemotherapy Dosing
The American Society of Clinical Oncology has released recommendations to help obese people living with cancer understand and discuss with their doctors the appropriate dosing of chemotherapy for their body weight.